Abdullah Ibrahim Haj-Yehia

This inventor holds 9 USPTO granted patents. Top assignees: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd., Oxon Medica Inc.. Active years: 1999-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Abdullah Ibrahim Haj-Yehia. Retrieved from https://idiyas.com/inventor/abdullah-ibrahim-haj-yehia

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9

% Patents Active = 55.6

Average Co-Inventor Count = 1.3

ph-index = 7

Forward Citations = 192(Granted Patents)

Location History:

Jerusalem, IL (1999 - 2005)
Neve Shalom, IL (2008)

Company Filing History:

6 out of 915

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.

Years Active: 1999-2008

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7378438 - Beta-agonist compounds comprising nitric oxide donor groups and reactive oxygen species scavenger groups and their use in the treatment of respiratory disorders (2008-05-27),

2. 6900338 - Scavenger compounds (2005-05-31),

3. 6759430 - Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress (2004-07-06),

4. 6642260 - Nitric oxide donors and pharmaceutical compositions containing them (2003-11-04),

5. 6492405 - Nitric oxide donors and pharmaceutical compositions containing them (2002-12-10),

6. 6455542 - Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress (2002-09-24),

7. 6448267 - Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress (2002-09-10),

8. 6369071 - Nitric oxide donors and pharmaceutical compositions containing them (2002-04-09),

9. 5880157 - Derivatives of tetramethylcyclopropane (1999-03-09),

Title: Innovations by Abdullah Ibrahim Haj-Yehia

Introduction

Abdullah Ibrahim Haj-Yehia is a notable inventor based in Neve Shalom, Israel. He has made significant contributions to the field of respiratory medicine through his innovative patents. With a total of 9 patents, his work focuses on developing compounds that address critical health issues.

Latest Patents

One of his latest patents involves beta-agonist compounds that comprise nitric oxide donor groups and reactive oxygen species scavenger groups. This invention is aimed at treating respiratory disorders, particularly those involving airway obstruction, such as asthma and chronic bronchitis. The invention also includes methods and devices for administering these compounds. Another significant patent he holds relates to novel scavenger compounds that possess anti-ROS properties. These compounds are designed for the treatment of conditions associated with oxidative stress or free radical injury.

Career Highlights

Throughout his career, Abdullah has worked with prominent organizations, including Yissum Research Development Company of the Hebrew University of Jerusalem and Oxon Medica Inc. His innovative work has positioned him as a key figure in the development of therapeutic solutions for respiratory conditions.

Collaborations

Abdullah has collaborated with notable professionals in his field, including Erik Emil Anggard and Jeff Sterling. These partnerships have further enhanced the impact of his inventions.

Conclusion

Abdullah Ibrahim Haj-Yehia's contributions to respiratory medicine through his innovative patents demonstrate his commitment to improving health outcomes. His work continues to influence the development of effective treatments for respiratory disorders.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]